Overview

A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia
Phase:
Phase 2
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride